In 2012, we received funding from the PIA (Future Investment Plan) for the creation of the National Infrastructure in Biology & Health IDMIT for "Modeling Infectious Diseases and Innovative Therapies". This national infrastructure benefits from the expertise and knowledge of its world-renowned founders: CEA, Institut Pasteur, University of Paris-Saclay/Paris-Sud, INSERM, ANRS and OncoDesign. The partners, all international leaders in the field of host/pathogen relationships, provide complementary expertise that results in a preclinical entity, unique in Europe in the field of infectious diseases affecting man.
Highly innovative technologies, such as flow cytometry coupled with mass spectrometry (CYTOF) in the FlowCytech laboratory and in vivo optical and nuclear Imaging (L3i Laboratory), are available to the entire scientific community.